DE255149T1 - Pyrrolidin-2-on-derivate mit nootroper aktivitaet. - Google Patents
Pyrrolidin-2-on-derivate mit nootroper aktivitaet.Info
- Publication number
- DE255149T1 DE255149T1 DE198787111127T DE87111127T DE255149T1 DE 255149 T1 DE255149 T1 DE 255149T1 DE 198787111127 T DE198787111127 T DE 198787111127T DE 87111127 T DE87111127 T DE 87111127T DE 255149 T1 DE255149 T1 DE 255149T1
- Authority
- DE
- Germany
- Prior art keywords
- formula
- iii
- derivatives
- compound
- given above
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- HNJBEVLQSNELDL-UHFFFAOYSA-N pyrrolidin-2-one Chemical class O=C1CCCN1 HNJBEVLQSNELDL-UHFFFAOYSA-N 0.000 title 1
- 150000001875 compounds Chemical class 0.000 claims 8
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 claims 6
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 2
- 229910052739 hydrogen Inorganic materials 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 2
- 238000000034 method Methods 0.000 claims 2
- 238000002360 preparation method Methods 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 1
- 150000007513 acids Chemical class 0.000 claims 1
- 239000004480 active ingredient Substances 0.000 claims 1
- 125000002252 acyl group Chemical group 0.000 claims 1
- 125000000217 alkyl group Chemical group 0.000 claims 1
- 125000003710 aryl alkyl group Chemical group 0.000 claims 1
- 230000002490 cerebral effect Effects 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 230000003340 mental effect Effects 0.000 claims 1
- 230000036997 mental performance Effects 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 230000001777 nootropic effect Effects 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 1
- 230000000506 psychotropic effect Effects 0.000 claims 1
- HNJBEVLQSNELDL-YZRHJBSPSA-N pyrrolidin-2-one Chemical class O=C1CC[14CH2]N1 HNJBEVLQSNELDL-YZRHJBSPSA-N 0.000 claims 1
- 229920006395 saturated elastomer Polymers 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- LMBFAGIMSUYTBN-MPZNNTNKSA-N teixobactin Chemical compound C([C@H](C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H](CCC(N)=O)C(=O)N[C@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CO)C(=O)N[C@H]1C(N[C@@H](C)C(=O)N[C@@H](C[C@@H]2NC(=N)NC2)C(=O)N[C@H](C(=O)O[C@H]1C)[C@@H](C)CC)=O)NC)C1=CC=CC=C1 LMBFAGIMSUYTBN-MPZNNTNKSA-N 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
- C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
- C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/24—Oxygen or sulfur atoms
- C07D207/26—2-Pyrrolidones
- C07D207/273—2-Pyrrolidones with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to other ring carbon atoms
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Hospice & Palliative Care (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Pyrrole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Claims (7)
1. Pyrrolidin-2-on-Derivate der Formel I
N-(CH ) -CO-NH-(CH ) -N 2 &eegr; 2 m
CH OH
worin X Wasserstoff oder eine OR-Gruppe bedeutet, wobei R eine der folgenden Bedeutungen besitzt: Wasserstoff,
C_-C7~Acyl, gesättigtes oder ungesättigtes C.-C^-Alkyl,
Cycloalkyl, Aralkyl oder Phenyl; &eegr; 0 oder 1 bedeutet und in 2 oder 3 bedeutet.
(I)
2. Verbindung nach Anspruch 1, worin X
und m = 2 bedeuten.
= H, &eegr; = 1
3. Verbindung nach Anspruch 1, worin X m = 2 bedeuten.
= OH, &eegr; = 1,
4. Verbindung nach Anspruch 1, worin X=H, &eegr; = 1 und m = 3 bedeuten.
5. Verfahren zur Herstellung von Verbindungen nach einem der Ansprüche 1 bis 4, dadurch gekennzeichnet , daß man die Verbindung der Formel II
) -COOR1 2 &eegr;
(II)
tt ■* ■-
0255U9
worin X1 die bereits für X gegebenen Bedeutungen besitzt,
ausgenommen eines Acyloxyrestes,und außerdem einen CH OCH2O- oder CH3OCH CH3O-ReSt bedeuten kann, R eine
niedrige Alkylgruppe, bevorzugt Methyl oder Ethyl, bedeutet und &eegr; und m die oben gegebenen Bedeutungen besitzen,
mit einer Verbindung der Formel III,
H N-(CH ) -N 2 2 m
(III)
worin m die oben gegebene Definition besitzt, umsetzt.
6. Verfahren zur Herstellung von Verbindungen nach einem der Ansprüche 1 bis 4, dadurch gekennzeichnet, daß die Carboxy-Gruppe der Säuren
der Formel (IV) mit N,N'-Carbonyldiimidazol (NCDI) oder mit 2-Ethoxy-l~ethoxycarbonyl-l,2-dihydrochinolin (EEDQ)
aktiviert wird und daß die so aktivierten Derivate (V) mit Verbindungen der Formel (III) entsprechend dem
Schema B umgesetzt werden,
N-(CII ) -COOH 2 &eegr;
Schema B
NCDI EEDQ
N-(CH )-COY
(IV)
(V)
(V) + NH -(CH ) -N 2 2 m
(III)
(I
0255U9
worin Y N oder -O-C-C H
Il 2 5
bedeutet und X, &eegr; und m die oben angegebenen Bedeutungen besitzen.
7. Pharmazeutische Zubereitungen mit nootropischerbzw. psychotropischerAktivität, insbesondere für die
Therapie von Mentalsyndromen infolge zerebraler Insuffizienz und Störungen der mentalen Leistung
älterer Patienten, dadurch gekennzeichnet daß sie als aktiven Bestandteil die Verbindungen nach einem
der Ansprüche 1 bis 4 enthalten.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT21397/86A IT1224168B (it) | 1986-08-01 | 1986-08-01 | Derivati del pirrolidin-2-one ad attivita' nootropa |
Publications (1)
Publication Number | Publication Date |
---|---|
DE255149T1 true DE255149T1 (de) | 1988-09-22 |
Family
ID=11181147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE198787111127T Pending DE255149T1 (de) | 1986-08-01 | 1987-07-31 | Pyrrolidin-2-on-derivate mit nootroper aktivitaet. |
Country Status (7)
Country | Link |
---|---|
US (1) | US4788212A (de) |
EP (1) | EP0255149A1 (de) |
JP (1) | JPS6341454A (de) |
DE (1) | DE255149T1 (de) |
ES (1) | ES2003063A4 (de) |
GR (1) | GR880300122T1 (de) |
IT (1) | IT1224168B (de) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1305148C (en) * | 1987-08-19 | 1992-07-14 | Hiromu Matsumura | Carbamoylpyrrolidone derivatives and drugs for senile dementia |
JPH075546B2 (ja) * | 1987-08-19 | 1995-01-25 | 塩野義製薬株式会社 | カルバモイルピロリドン誘導体 |
US5237073A (en) * | 1988-08-26 | 1993-08-17 | Sepracor, Inc. | Derivatives and precursors of captopril and its analogues |
EP0432204A4 (en) * | 1988-08-26 | 1992-08-12 | Sepracor, Inc. | Derivatives and precursors of captopril and its analogues |
JPH02155683A (ja) * | 1988-12-07 | 1990-06-14 | Nec Corp | ファクシミリ装置 |
NZ232112A (en) * | 1989-01-17 | 1992-07-28 | Hoffmann La Roche | ((5-oxo-2-pyrrolidinyl)methyl)cyclohexaneacetamides, intermediates therefor and pharmaceutical compositions |
IT1231477B (it) * | 1989-07-12 | 1991-12-07 | Sigma Tau Ind Farmaceuti | (pirrolidin-2-one-1-il) acetammidi quali attivatori dei processi di apprendimento e della memoria e composizioni farmaceutiche comprendenti tali composti |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1039113A (en) * | 1964-08-06 | 1966-08-17 | Ucb Sa | New n-substituted lactams |
IT1045043B (it) * | 1975-08-13 | 1980-04-21 | Isf Spa | Derivati pirrolidinici |
FR2515179A1 (fr) * | 1981-07-24 | 1983-04-29 | Hoffmann La Roche | Derives de pyrrolidine, leur procede de preparation, les intermediaires pour leur synthese et leur application therapeutique |
-
1986
- 1986-08-01 IT IT21397/86A patent/IT1224168B/it active
-
1987
- 1987-07-29 US US07/079,172 patent/US4788212A/en not_active Expired - Fee Related
- 1987-07-31 JP JP62190581A patent/JPS6341454A/ja active Pending
- 1987-07-31 DE DE198787111127T patent/DE255149T1/de active Pending
- 1987-07-31 EP EP87111127A patent/EP0255149A1/de not_active Withdrawn
- 1987-07-31 ES ES87111127T patent/ES2003063A4/es active Pending
-
1988
- 1988-12-16 GR GR88300122T patent/GR880300122T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
JPS6341454A (ja) | 1988-02-22 |
GR880300122T1 (en) | 1988-12-16 |
IT8621397A0 (it) | 1986-08-01 |
IT1224168B (it) | 1990-09-26 |
ES2003063A4 (es) | 1988-10-16 |
EP0255149A1 (de) | 1988-02-03 |
US4788212A (en) | 1988-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE69305419T2 (de) | Prostaglandin-I 2-Derivate enthaltende Haarwuchsmittel | |
WO1998052549B1 (de) | Verwendung von fumarsäurederivaten | |
DE3146772C2 (de) | Verwendung von Xanthogenatverbindungen, neue Xanthogenatverbindungen und ein Verfahren zu ihrer Herstellung | |
DE312867T1 (de) | Gallensaeure-derivate, verfahren zu ihrer herstellung und pharmazeutische praeparate, die sie enthalten. | |
DE2558501A1 (de) | Verfahren zur herstellung von alpha, alpha, alpha-trisubstituierten acetamiden, acetonitrilen und methanen und diese verbindungen enthaltende pharmazeutische zubereitungen | |
DE3415413A1 (de) | Melanin-inhibitor | |
DE2102172A1 (de) | Neue Mitel zur Behandlung und Pflege der Haut | |
DE255149T1 (de) | Pyrrolidin-2-on-derivate mit nootroper aktivitaet. | |
EP0079913B1 (de) | Arencarbonsäure-derivate als antiseborrhoische zusätze für kosmetische mittel | |
DE69720600T2 (de) | Mittel zur Verhinderung von schlechten Gerüchen | |
DE2609399C2 (de) | 9-Desoxy-9-methylen-16,16-dimethyl-prostaglandinderivate und Verfahren zu deren Herstellung | |
EP0270482B1 (de) | Verwendung von 5-(Subst. Phenyl)- Oxazolidinonderivaten zur Behandlung von Depressionen | |
DE60031791T2 (de) | Verwendung aromatischer polycyclischer Verbindungen als Aktivatoren der Rezeptoren vom Typ der PPARs in einer kosmetischen oder pharmazeutischen Zusammensetzung | |
EP0320785A3 (de) | Peptide mit beeinflussender Wirkung auf die Hypophyse von Säugern | |
DE1493083B1 (de) | Linolsaeureamide und Verfahren zu ihrer Herstellung | |
DE2038628C3 (de) | N,N'-Di(carboxyalkyI)-p-phenylendiamine, deren Salze und Diäthylester, Verfahren zu ihrer Herstellung und ihre Verwendung | |
DE223671T1 (de) | Arzneimittel mit synergistischer entzuendungshemmender wirkung auf der basis eines corticosteroiden und eines beta-agonisten. | |
WO1986000892A1 (en) | New compounds having an immunizing activity | |
DE197856T1 (de) | Zusammensetzung fuer baeder auf basis von psoralen in der behandlung von psoriasis. | |
DE1908574A1 (de) | Neue antiseborrhoeische Verbindungen,Verfahren zu ihrer Herstellung,kosmetische Mittel,Shampoos und oral verabreichbare Produkte mit einem Gehalt an diesen neuen Verbindungen | |
DE871896C (de) | Verfahren zur Herstellung des Nicotinsaeure-[ª-(N-morpholino)-aethyl]-esters | |
DE2320945A1 (de) | Neue ester der acetylsalicylsaeure | |
DE326326T1 (de) | Cysteinderivate. | |
DE2438884A1 (de) | Neue derivate des 5-hydroxymethylthiazols, verfahren zu ihrer herstellung und pharmazeutische zusammensetzungen | |
WO1982004391A1 (en) | Derivatives of aryl and hetero-aryl-mercapto-alkanoic acids as additives having an anti-seborrhea activity for cosmetic products |